Same Indication

Metformin vs Nivolumab

Metformin vs Nivolumab: Overview

This comparison examines the pharmacological differences between Metformin and Nivolumab.

Mechanism of Action

Metformin: Activates AMP-activated protein kinase, decreasing hepatic glucose production.

Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

Pharmacokinetics

Half-life: Metformin β€” 4-9 hours; Nivolumab β€” 27 days.

Chemical Properties

Molecular Formula: Metformin β€” C4H11N5.

Molecular Weight: Metformin β€” 129.1640 g/mol.

Type: Metformin β€” Small molecule; Nivolumab β€” Antibody.